2024 Laboratory Reimbursement Trends and What to Expect in 2025
Revenue cycle management experts weigh in on the biggest developments of 2024 and how labs can best prepare for 2025 and beyond
Revenue cycle management experts weigh in on the biggest developments of 2024 and how labs can best prepare for 2025 and beyond
The company is hiring at least 100 sales representatives this year to spread awareness and uptake of its recently FDA-approved Shield test
Direct-to-consumer (DTC) genetic testing has risen in popularity in recent years—but is it all it’s cracked up to be?
As the field of genetic testing grows, genetic counselors can help labs meet patients’ needs and keep up with new developments
Two revenue cycle management experts offer tips for clinical labs to improve coverage decisions for genetic tests
For clinical labs, the proposed law could bring more consistency to test ordering
The roughly $1 billion deal will boost the company’s annual revenue by about 7 percent, and will give Quest a stronger presence in Canada
The US Supreme Court decision that recently overturned the Chevron doctrine is influencing potential enactment of new legislation
Recent DOJ settlements continue to focus on issues involving medical necessity and marketer compensation
How the MolDX® program works, what it covers, and how it can support better test access, use, and reimbursement in the clinical lab
The current landscape of medical laboratory networks and challenges that will need to be addressed to improve data sharing and efficiency.